Apolipoprotein A-V (APOA5) antibody
| Antigen |
|
| Synonyms |
RAP3, Apoav, 1300007O05Rik, APOAV, APOA-V, MGC126836, MGC126838, MGC108612, APOA5, MGC140487, rap3, apoav, apoa-v |
| Clonality |
Monoclonal (1G5G9) |
|
Host
|
|
|
Reactivity
|
|
|
Conjugate
|
Alexa Fluor 350 (1), Alexa Fluor 488 (1), Alexa Fluor 555 (1), Alexa Fluor 647 (1), Biotin (1), Cy3 (1), Cy5 (1), Cy5.5 (1), Cy7 (1), FITC (1), Gold (1), HRP (1), PE (1), PE,Cy3 (1), PE,Cy5 (1), PE,Cy5.5 (1), PE,Cy7 (1)
|
|
Application
|
|
| Catalog no. |
ABIN268873 |
| Quantity |
25 µl (3.6 mg/ml) (Variants) |
| Price |
Product not available in this region.
|
|
|
| Shipping to |
|
|
Alternative name
|
Apolipoprotein A V (ApoA V)
|
|
Gene ID
|
116519
|
|
Immunogen
|
Ni-NTA purified full-length recombinant human APOA5 expressed in E. Coli strain BL21(DE3).
|
|
Cross-Reactivity
|
Human
|
|
Isotype
|
IgG1
|
|
Clone
|
1G5G9
|
|
Description
|
Apolipoprotein A5 (ApoA5) is fast gaining attention as a key regulator of serumtriglyceride concentrations. An ApoA5 mouse knock-out model produced anapproximately four-fold increase in serum triglycerides, whereas a knock-in model withhuman ApoA5 produced 50-70% lower concentrations of mouse serum triglycerides. Inaddition, peroxisome proliferator-activated receptor-4 (PPAR-alpha) agonists, which areused clinically to lower serum triglyceride concentrations, cause increased ApoA5mRNA expression. Recently, it was demonstrated that ApoA5 is present in humanserum detected by polyclonal antibodies against both the NH2 and COOH termini,although at much lower concentrations than other apolipoproteins. Alternate Names: anti-Apo-A5 antibody, anti-ApoA5 antibody, anti-Apolipoprotein A5 antibody, anti-ApoA-V antibody, anti-Apolipoprotein A-V antibody, anti-ApoA-V antibody. Related Diseases: Coronary Artery Disease, Hypertriglyceridemia
|
|
Specificity
|
Species Reactivity: Reacts with human. 83% sequence identity with Bovine, 79% sequence identity withRat, 78% sequence identity with Mouse proteins.
|
|
Application Notes
|
Suggested working dilutions: Western Blot 1:500-1:2,000 (ECL). Positive Controls: HEPG2 cells
|
|
Concentration
|
3.6 mg/ml
|
|
Storage
|
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
|
|
Research Area
|
Metabolism
|
|
Restrictions
|
For Research Use only
|
|
|
Pennacchio, Olivier, Hubacek et al.: "An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing." in: Science (New York, N.Y.), Vol. 294, Issue 5540, pp. 169-73, 2001 (PubMed).
Prieur, Coste, Rodriguez: "The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element." in: The Journal of biological chemistry, Vol. 278, Issue 28, pp. 25468-80, 2003 (PubMed).
|
Alternatives for antigen "Apolipoprotein A-V (APOA5)", type "Antibodies"
|
Hosts
|
Rabbit (31), Mouse (25), Goat (4)
|
|
Reactivities
|
Human (59), Rat (Rattus) (21), Mouse (Murine) (20), Dog (Canine) (18), Horse (Equine) (18), Chicken (3)
|
|
Applications
|
Western Blotting (WB) (40), ELISA (39), Immunofluorescence (IF) (16), Immunohistochemistry (IHC) (6), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) (5), Immunohistochemistry (Formalin-fixed Sections) (IHC (f)) (3), Immunocytochemistry (ICC) (2), Immunoprecipitation (IP) (2), Immunoelectron Microscopy (IEM) (1), Immunohistochemistry (Frozen Sections) (IHC (fro)) (1)
|
|
Conjugates
|
Alexa Fluor 350 (1), Alexa Fluor 488 (1), Alexa Fluor 555 (1), Alexa Fluor 647 (1), Biotin (1), Cy3 (1), Cy5 (1), Cy5.5 (1), Cy7 (1), FITC (1), Gold (1), HRP (1), PE (1), PE,Cy3 (1), PE,Cy5 (1), PE,Cy5.5 (1), PE,Cy7 (1)
|
|
Epitopes
|
N-Term (5), C-Term (3)
|